Head and Neck Cancer: Clinical Trials

1,628 trials for Head and Neck Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

828 completed, 223 recruiting, 200 unknown, 169 terminated. 511 Phase 2, 411 Not applicable, 322 Phase 1, 119 Phase 3, 36 Early Phase 1.

By phase and status

PhaseTrialsStatus
Phase 2511Completed 271, Terminated 68, Recruiting 65, Unknown 50, Active not recruiting 24, Withdrawn 21, Not yet recruiting 11, Enrolling by invitation 1
Not applicable411Completed 194, Recruiting 68, Unknown 50, Terminated 31, Withdrawn 23, Active not recruiting 21, Not yet recruiting 18, Suspended 5, Enrolling by invitation 1
Phase 1322Completed 172, Terminated 48, Recruiting 40, Unknown 29, Active not recruiting 16, Withdrawn 10, Not yet recruiting 6, Suspended 1
Phase 3119Completed 63, Unknown 19, Terminated 16, Withdrawn 8, Active not recruiting 6, Recruiting 5, Not yet recruiting 2
Early Phase 136Completed 17, Terminated 6, Unknown 5, Active not recruiting 2, Not yet recruiting 2, Recruiting 2, Withdrawn 2
Phase 425Completed 14, Unknown 4, Active not recruiting 2, Recruiting 2, Withdrawn 2, Terminated 1

Follow Head and Neck Cancer: new trials by email Literature Review of Head and Neck Cancer trials Research Report on Head and Neck Cancer

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Ph2, Colchicine For Inflammatory Carotid Injury And Disease Evolution After Radiotherapy
Colchicine, Placebo - Head and Neck Cancer
Phase 2Not yet recruitingM.D. Anderson Cancer Center2502027-03-012026-10-05
Understanding the Role of MyCareGorithm as a Visual Digital Platforms in Cancer Treatment Education and Patient Comprehension of Oncology Treatment Plans
Survey - Head and Neck Cancer, Prostate Cancer
Not applicableNot yet recruitingM.D. Anderson Cancer Center942027-03-012026-10-01
Maximizing Quality of Life After Cancer Through Rehabilitation
TIMELY REHAB - Head and Neck Cancer, Hearing Loss
Not applicableNot yet recruitingVA Office of Research and Development742027-03-012026-06-03
Impact of Chronic MICROplastic Exposure on RADiotherapy of Head and Neck Cancer Patients: Clinical and Translational Oncology Study:
Head and Neck Cancer, Microplastic Exposure
Not yet recruitingUniversity of Kragujevac5002027-02-012026-11-06
A Study of LG00313112 in Participants With Advanced Solid Malignancies Harboring a TP53 Y220C Mutation
LG00313112 - Ovarian Cancer, Small Cell Lung Cancer
Phase 1 / Phase 2Not yet recruitingLG Chem2502026-12-012026-08-07
Head and Neck Cancer Patients With Oral Mucositis Treated With Ketamine Oral Rinse
Placebo, Ketamine Topical - Head and Neck Cancer
Phase 2Not yet recruitingUniversity of Oklahoma622026-12-012026-10-16
Predictive Factors of Long-term Survivor (LTS) of Patients With Recurrent or Metastatic, Radio-iodine Resistant Differentiated Thyroid Cancer (RRDTC) After Lenvatinib: a Multicenter Study
Head and Neck Cancer
Not yet recruitingIRCCS San Raffaele652026-12-012026-11-10
SumMET: Study of [225Ac]Ac-FL-261 in Participants With Solid Tumors Overexpressing c-MET
[225Ac]Ac-FL-261 - Solid Tumor, NSCLC
Phase 1 / Phase 2RecruitingFull-Life Technologies UK Limited2082026-12-012026-11-16
Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer
SX-682, DTX - Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma
Phase 1 / Phase 2RecruitingNational Cancer Institute (NCI)1202026-11-242026-11-19
Resistance Training and Creatine Supplementation for Head and Neck Cancer
Creatine Supplementation, Resistance Training - Head and Neck Cancer, Cancer Survivorship
Not applicableNot yet recruitingMedical University of South Carolina302026-11-152026-10-06
Circulating Tumor DNA-Informed Adjuvant Therapy for Intermediate-Risk Head and Neck Cancer
Cisplatin or carboplatin, Intensity-modulated radiation therapy (IMRT) or Intensity-modulated proton therapy (IMPT), Pembrolizumab - Head and Neck Cancer
Phase 2Not yet recruitingKevin Contrera1402026-11-152026-11-12
Phase 2 Study of RiMO-301 for the Neoadjuvant Treatment of Resectable, Locally Advanced Head-Neck Cancer
RiMO-301, Pembrolizumab, Radiation - Head and Neck Cancer, Head Cancer
Phase 2RecruitingUniversity of Illinois Chicago202026-11-092026-11-16
Bevonescein for Improved Intraoperative Nerve Visualization to Improve Voice Outcomes in Thyroidectomy Patients
Bevonescein (ALM 488) Infusion - Head and Neck Disorder, Head and Neck Cancer
Phase 2RecruitingMatthew Spector402026-11-042026-11-10
SALI-10 Probiotic to Reduce Osteoradionecrosis and Dental Toxicity Following Radiation Therapy for Head and Neck Cancer
Standard of Care (SOC), Experimental drug - Head and Neck Cancer
Phase 3Not yet recruitingUniversity Health Network, Toronto2882026-11-012026-10-20
Analysis of Breath Volatile Organic Compounds Using Mass Spectrometry
Proton Transfer Reaction Mass Spectrometry Analysis - Pancreas Cancer, Hepatocellular Carcinoma
Not yet recruitingUniversity of Oklahoma20002026-11-012026-11-18
FLASH Biomarker Study
Head and Neck Cancer
Not yet recruitingAbramson Cancer Center at Penn Medicine102026-11-012026-11-17
A Single Arm Phase II Trial in p16-positive Oropharynx Cancer of Selective Dose De-escalation of nodAl VolumEs at Minimal Risk and Primary Site Disease (SAVED)
Dose de-escalation to contralateral neck., Dose de-escalation to gross disease to contralateral neck, Dose de-escalation to gross disease - Head and Neck Cancer, Head and Neck Squamous Cell Cancer
Phase 2RecruitingUniversity of Maryland, Baltimore1322026-10-192026-11-06
Iparomlimab and Tuvonralimab With With Cetuximab in Resectable OSCC
iparomlimab and tuvonralimab combined with cetuximab - Head and Neck Cancer
Phase 2RecruitingShanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University262026-10-162026-10-20
Comparing Radiotherapy Immobilization Systems for Anxious HNC Patients
OSMS position management - Head and Neck Cancer, Claustrophobia
Not applicableNot yet recruitingCentre hospitalier de l'Université de Montréal (CHUM)152026-10-152026-08-19
Safety and Tolerability of Metformin and Naproxen for Cancer Prevention in Fanconi Anemia
Metformin, Naproxen Sodium - Fanconi Anemia, Head and Neck Cancer
Phase 1RecruitingRockefeller University802026-10-142026-10-28

Showing 20 of 1628. Sign in to see all of them.

Narrower conditions

Head and Neck Neoplasms (1628)  ·  Squamous Cell Carcinoma of Head and Neck (371)  ·  Lung Neoplasms (172)  ·  Breast Neoplasms (148)  ·  Neoplasms (122)  ·  Carcinoma, Non-Small-Cell Lung (120)  ·  Salivary Gland Neoplasms (100)  ·  Colorectal Neoplasms (95)  ·  Mouth Neoplasms (95)  ·  Ovarian Neoplasms (92)  ·  Pancreatic Neoplasms (92)  ·  Oropharyngeal Neoplasms (91)  ·  Melanoma (86)  ·  Esophageal Neoplasms (85)  ·  Carcinoma, Squamous Cell (82)

Broader conditions

Neoplasms by Site (1627)  ·  Neoplasms (1506)  ·  Neoplasms by Histologic Type (629)  ·  Neoplasms, Glandular and Epithelial (558)  ·  Carcinoma (510)  ·  Carcinoma, Squamous Cell (354)  ·  Stomatognathic Diseases (325)  ·  Respiratory Tract Diseases (324)  ·  Respiratory Tract Neoplasms (299)  ·  Digestive System Diseases (280)  ·  Mouth Diseases (271)  ·  Gastrointestinal Diseases (258)  ·  Lung Diseases (249)  ·  Thoracic Neoplasms (246)  ·  Digestive System Neoplasms (234)

Interventions

Cisplatin (178)  ·  Radiotherapy (145)  ·  Cetuximab (99)  ·  Docetaxel (68)  ·  Fluorouracil (64)  ·  pembrolizumab (62)  ·  Paclitaxel (60)  ·  Carboplatin (58)  ·  Radiotherapy, Intensity-Modulated (51)  ·  Surveys and Questionnaires (38)  ·  Nivolumab (27)  ·  Radiation (27)  ·  Drug Therapy (23)  ·  Erlotinib Hydrochloride (22)  ·  Gemcitabine (21)

Sponsors

M.D. Anderson Cancer Center (57)  ·  Memorial Sloan Kettering Cancer Center (43)  ·  Radiation Therapy Oncology Group (26)  ·  National Cancer Institute (NCI) (24)  ·  Vanderbilt-Ingram Cancer Center (23)  ·  University of Chicago (21)  ·  Dana-Farber Cancer Institute (20)  ·  Wake Forest University Health Sciences (20)  ·  University Health Network, Toronto (19)  ·  Stanford University (17)  ·  Washington University School of Medicine (17)  ·  Case Comprehensive Cancer Center (16)  ·  Eastern Cooperative Oncology Group (16)  ·  Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (16)  ·  Royal Marsden NHS Foundation Trust (15)

Countries

United States (872)  ·  Canada (119)  ·  France (106)  ·  United Kingdom (95)  ·  China (79)  ·  Italy (66)  ·  Belgium (57)  ·  Netherlands (54)  ·  Spain (53)  ·  Germany (50)  ·  Taiwan (47)  ·  South Korea (37)  ·  Australia (30)  ·  Switzerland (23)  ·  Denmark (20)

Top investigators

Barbara Murphy, MD (12)  ·  Quynh-Thu Le (7)  ·  Athanassios Argiris, MD (6)  ·  Corey J. Langer, MD (6)  ·  Jared Weiss, MD (6)  ·  Lillian Siu, MD (6)  ·  Electron Kebebew, MD (5)  ·  Nancy Lee, MD (5)  ·  David G. Pfister, MD (4)  ·  David J. Adelstein, MD (4)  ·  Eben Rosenthal, MD (4)  ·  Everett Vokes, MD (4)

Results publications

PMID 25057165, PMID 25081901, PMID 31420360, PMID 41343184, PMID 12383306, PMID 15128893, PMID 16467544, PMID 17960012, PMID 30548235, PMID 33340075, PMID 35304084, PMID 37142273, PMID 10071296, PMID 10430262, PMID 10443845, PMID 10444409, PMID 10637264, PMID 10764008, PMID 10772298, PMID 10917373, PMID 10924966, PMID 10961810, PMID 11323096, PMID 11359154, PMID 11560968, PMID 11712783, PMID 11756581, PMID 11822946, PMID 11870186, PMID 12122555, PMID 12361079, PMID 12499279, PMID 12525193, PMID 12525530, PMID 12560776, PMID 12625522, PMID 12676044, PMID 12721240, PMID 12734880, PMID 12788192, PMID 12988177, PMID 14508838, PMID 14529772, PMID 14567906, PMID 14585260, PMID 14616150, PMID 14645636, PMID 14755223, PMID 15033677, PMID 15128894

NIH funding

P30CA068485 (17), P30CA006516 (12), U10CA032102 (11), 2023 (8), 2017 (7), P30CA043703 (7), P30CA012197 (6), P30CA006973 (4), P30CA015083 (4), P30CA016672 (4), P30CA022453 (4), U10CA021115 (4), 2016 (3), P30CA023074 (3), 2005 (2)